LIFR
Summary: This gene encodes a protein that belongs to the type I cytokine receptor family. This protein combines with a high-affinity converter subunit, gp130, to form a receptor complex that mediates the action of the leukemia inhibitory factor, a polyfunctional cytokine that is involved in cellular differentiation, proliferation and survival in the adult and the embryo. Mutations in this gene cause Schwartz-Jampel syndrome type 2, a disease belonging to the group of the bent-bone dysplasias. A translocation that involves the promoter of this gene, t(5;8)(p13;q12) with the pleiomorphic adenoma gene 1, is associated with salivary gland pleiomorphic adenoma, a common type of benign epithelial tumor of the salivary gland. Multiple splice variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2018].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
LIF receptor alpha | MIM:151443 | Ensembl:ENSG00000113594 | HGNC:HGNC:6597 | PA30371 | 5p13.1 |
Gene Categories:
DRUGGABLE GENOMEGO terms in LIFR
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004896 | cytokine receptor activity |
MF | IDA | GO:0004897 | ciliary neurotrophic factor receptor activity |
MF | IBA | GO:0004923 | leukemia inhibitory factor receptor activity |
MF | IDA | GO:0004923 | leukemia inhibitory factor receptor activity |
MF | IDA | GO:0004923 | leukemia inhibitory factor receptor activity |
MF | IBA | GO:0004924 | oncostatin-M receptor activity |
MF | IDA | GO:0004924 | oncostatin-M receptor activity |
MF | IBA | GO:0005127 | ciliary neurotrophic factor receptor binding |
MF | IPI | GO:0005127 | ciliary neurotrophic factor receptor binding |
MF | IPI | GO:0005515 | protein binding |
MF | IPI | GO:0019838 | growth factor binding |
MF | IBA | GO:0019955 | cytokine binding |
CC | TAS | GO:0005886 | plasma membrane |
CC | TAS | GO:0005887 | integral component of plasma membrane |
CC | IBA | GO:0009897 | external side of plasma membrane |
CC | IBA | GO:0043235 | receptor complex |
CC | IDA | GO:0043235 | receptor complex |
CC | HDA | GO:0070062 | extracellular exosome |
BP | TAS | GO:0001959 | regulation of cytokine-mediated signaling pathway |
BP | TAS | GO:0007166 | cell surface receptor signaling pathway |
BP | IBA | GO:0008284 | positive regulation of cell proliferation |
BP | IDA | GO:0008284 | positive regulation of cell proliferation |
BP | IDA | GO:0019221 | cytokine-mediated signaling pathway |
BP | TAS | GO:0019221 | cytokine-mediated signaling pathway |
BP | IDA | GO:0034097 | response to cytokine |
BP | IMP | GO:0038165 | oncostatin-M-mediated signaling pathway |
BP | IDA | GO:0048861 | leukemia inhibitory factor signaling pathway |
BP | IDA | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway |
Gene expression in normal tissue: LIFR
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in LIFR
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP1528 | Physiological and Pathological Hypertrophy of the Heart |
wikipathways | WP236 | Adipogenesis |
wikipathways | WP2374 | Oncostatin M Signaling Pathway |
wikipathways | WP3931 | ESC Pluripotency Pathways |
wikipathways | WP4105 | Transcriptional regulation by RUNX1 |
kegg | hsa04060 | Cytokine-cytokine receptor interaction - Homo sapiens (human) |
kegg | hsa04550 | Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human) |
kegg | hsa04630 | Jak-STAT signaling pathway - Homo sapiens (human) |
netpath | Pathway_Oncostatin_M | Oncostatin_M |
reactome | R-HSA-1280215 | Cytokine Signaling in Immune system |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-449147 | Signaling by Interleukins |
reactome | R-HSA-6783589 | Interleukin-6 family signaling |
reactome | R-HSA-6788467 | IL-6-type cytokine receptor ligand interactions |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8878171 | Transcriptional regulation by RUNX1 |
reactome | R-HSA-8939247 | RUNX1 regulates transcription of genes involved in interleukin signaling |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD446 | LY 2183240 | 1 |
iGMDRD193 | Fqi1 | 4 |
iGMDRD280 | CYTOCHALASIN B | 5 |
iGMDRD433 | Lexibulin | 1 |
iGMDRD151 | CHM-1 | 3 |
iGMDRD599 | Salermide | 4 |
iGMDRD420 | Leucascandrolide A | 3 |
iGMDRD779 | PRL-3 Inhibitor I | 1 |
iGMDRD483 | SCH-529074 | 2 |
iGMDRD494 | Neopeltolide | 1 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD188 | Piperlongumine | 6 |
iGMDRD100 | Zebularine | 7 |
iGMDRD399 | Selumetinib | 3 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD506 | Fedratinib | 2 |
iGMDRD888 | Compound 44 | 3 |
iGMDRD780 | PP-30 | 1 |
iGMDRD64 | Parbendazole | 6 |
iGMDRD356 | PNU-74654 | 1 |
iGMDRD138 | PX 12 | 2 |
iGMDRD260 | FQI-2 | 3 |
iGMDRD255 | SB225002 | 1 |
iGMDRD802 | 4-methylfasudil | 3 |
iGMDRD171 | Pemetrexed | 2 |
iGMDRD318 | PAC-1 | 1 |
iGMDRD187 | BRD9876 | 6 |
iGMDRD341 | Triacsin c | 3 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD536 | PLX-4720 | 1 |
iGMDRD57 | Chloropentafluorobenzene | 4 |
iGMDRD901 | ELCPK | 3 |
iGMDRD123 | Isoevodiamine | 3 |
iGMDRD154 | NSC23766 | 6 |
iGMDRD945 | ML214 | 2 |
iGMDRD150 | RITA | 3 |
iGMDRD424 | Tamatinib | 2 |
iGMDRD405 | PIK-75 | 2 |
iGMDRD79 | Gemcitabine | 2 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD329 | Merck60 | 6 |
iGMDRD662 | JQ-1 | 2 |
iGMDRD505 | Pevonedistat | 2 |
iGMDRD246 | NPC26 | 2 |
iGMDRD158 | NSC141540 | 4 |
iGMDRD705 | Nakiterpiosin | 3 |
iGMDRD6 | AM-580 | 2 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD77 | Itraconazole | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in LIFR